Skip to main content
. Author manuscript; available in PMC: 2015 Feb 16.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2014 Feb 14;7(2):244–250. doi: 10.1161/CIRCEP.113.000548

Table 1.

Comparison of Baseline Characteristics of Patients Undergoing Ventricular Tachycardia Ablation With Different Percutaneous Left Ventricular Assist Devices

IABP (N=22) Non-IABP Combined
(N=44)
Non-IABP Subgroups Total (N=66) P Value (IABP vs
Non-IABP)

Impella (N=25) TandemHeart (N=19)
Age, y, mean±SD 69±10 66±12 68±12 62±13 67±12 0.234
Male sex, % 21 (96) 41 (93) 23 (92) 18 (95) 62 (94) 0.715
Ischemic cardiomyopathy, % 16 (73) 29 (66) 16 (64) 13 (68) 45 (68) 0.575
Previous VT ablation, % 7 (32) 15 (34) 7 (28) 8 (42) 22 (33) 0.854
LVEF, % 25±10 29±15 33±14 23±13 28±13 0.213
ICU status, % 13 (59) 19 (43) 9 (36) 10 (53) 32 (49) 0.223
No. of ICD shocks, mean±SD 11±10 11±9.7 7±8 17±9 11±10 0.911
No. of ATP, mean±SD 28±23 26±29 24±35 29±18 27±27 0.756
No. of AADs failed, mean±SD 1.8±1.0 2.0±1.0 1.4±1.0 2.6±0.6 1.9±1.0 0.260

AAD indicates antiarrhythmic drug; ATP, antitachycardia pacing; CRT-D, cardiac resynchronization therapy-defibrillator; IABP, intra-aortic balloon pump; ICD, implantable cardiac defibrillator; ICU, intensive care unit; LVEF, left ventricular ejection fraction; and VT, ventricular tachycardia.